FLIP and FasL expression by inflammatory cells vs thyrocytes can be predictive of chronic inflammation or resolution of autoimmune thyroiditis

Clinical Immunology

Volumn 108, Issue 3, 2003, Pages 221-233

  Wei, Yongzhong ^a   Chen, Kemin ^a   Sharp, Gordon C ^a   Braley Mullen, Helen ^a,b  

^a University of Missouri   (United States)

^b VA Research Service   (United States)

Author keywords

Apoptosis; Autoimmunity; FLIP; Inflammation; Thyroiditis

Indexed keywords

CASPASE 3; CASPASE 8; FAS ANTIGEN; FAS LIGAND; FLICE INHIBITORY PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; HASHIMOTO DISEASE; INFLAMMATION; INFLAMMATORY CELL; MALE; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

EID: 0141453845     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6616(03)00146-3     Document Type: Article

References (48)

1. Charreire J. Immune mechanisms in autoimmune thyroiditis. Adv. Immunol. 46:1989;263-334.
2. Braley-Mullen H., Sharp G.C., Medling B., Tang H. Spontaneous autoimmune thyroiditis in NOD.H-2h4 mice. J. Autoimmunity. 12:1999;157-165.
3. Hutchings P.R., Verma S., Phillips J.M., Harach S.Z., Howlett S., Cooke A. Both CD4(+) T cells and CD8(+) T cells are required for iodine accelerated thyroiditis in NOD mice. Cell. Immunol. 192:1999;113-121.
4. Rasooly L., Burek C.L., Rose N.R. Iodine-induced autoimmune thyroiditis in NOD-H-2h4 mice. Clin. Immunol. Immunopathol. 81:1996;287-292.
5. Braley-Mullen H., Sharp G.C., Tang H., Chen K., Kyriakos M., Bickel J.T. Interleukin-12 promotes activation of effector cells that induce a severe destructive granulomatous form of murine experimental autoimmune thyroiditis. Am. J. Pathol. 152:1998;1347-1358.
6. Braley-Mullen H., Sharp G.C. Adoptive transfer murine model of granlomatous experimental autoimmune thyroiditis. Int. Rev. Immunol. 19:2000;535-555.
7. Braley-Mullen H., Sharp G.C., Bickel J.T., Kyriakos M. Induction of severe granulomatous experimental autoimmune thyroiditis in mice by effector cells activated in the presence of anti-interleukin 2 receptor antibody. J. Exp. Med. 173:1991;899-912.
8. Stassi G., Di Liberto D., Todaro M., Zeuner A., Ricci-Vitiani L., Stoppacciaro A., Ruco L., Farina F., Zummo G., De Maria R. Control of target cell survival in thyroid autoimmunity by T helper cytokines via regulation of apoptotic proteins. Nature Immunol. 1:2000;483-488.
9. Giordano C., Richiusa P., Bagnasco M., Pizzolanti G., Di Blasi F., Sbriglia M.S., Mattina A., Pesce G., Montagna P., Capone F., Misiano G., Scorsone A., Pugliese A., Galluzzo A. Differential regulation of Fas-mediated apoptosis in both thyrocyte and lymphocyte cellular compartments correlates with opposite phenotypic manifestations of autoimmune thyroid disease. Thyroid. 11:2001;233-244.
10. Stassi G., De Maria R. Autoimmune thyroid disease new models of cell death in autoimmunity . Nature Rev. Immunol. 2:2002;195-204.
11. Wei Y., Chen K., Sharp G.C., Yagita H., Braley-Mullen H. Expression and regulation of Fas and Fas ligand on thyrocytes and infiltrating cells during induction and resolution of granulomatous experimental autoimmune thyroiditis. J. Immunol. 167:2001;6678-6686.
12. Nagata S., Golstein P. The Fas death factor. Science. 267:1995;1449-1456.
13. Thome M., Tschopp J. Regulation of lymphocyte proliferation and death by FLIP. Nature Rev. Immunol. 1:2001;50-58.
14. Podolin P.L., Pressey A., DeLarato N.H., Fischer P.A., Peterson L.B., Wicker L.S. I-E+ nonobese diabetic mice develop insulitis and diabetes. J. Exp. Med. 178:1993;793-803.
15. Braley-Mullen H., McMurray R.W., Sharp G.C., Kyriakos M. Regulation of the induction and resolution of granulomatous experimental autoimmune thyroditis in mice by CD8+ T cells. Cell. Immunol. 153:1994;492-504.
16. Yu S., Medling B., Yagita H., Braley-Mullen H. Characteristics of inflammatory cells in spontaneous autoimmune thyroiditis of NOD.H-2h4 mice. J. Autoimmunity. 16:2001;37-46.
17. Tang H., Braley-Mullen H. Intravenous administration of deaggregated mouse thyroglobulin suppresses induction of experimental autoimmune thyroiditis and expression of both Th1 and Th2 cytokines. Int. Immunol. 9:1997;679-687.
18. Tang H., Chen K., Wei Y., Sharp G.C., McKee L., Braley-Mullen H. Apoptosis of thyrocytes and effector cells during induction and resolution of granulomatous experimental autoimmune thyroiditis. Int. Immunol. 12:2000;1629-1639.
19. Wildbaum G., Westermann J., Maor G., Karin N.A. Targeted DNA vaccine encoding Fas ligand defines its dual role in the regulation of experimental autoimmune encephalomyelitis. J. Clin. Invest. 106:2000;671-679.
20. De Maria R., Testi R. Fas-FasL interactions a common pathogenetic mechanism in organ-specific autoimmunity . Immunol. Today. 19:1998;121-125.
21. Zhang H., Yang Y., Horton J.L., Samoilova E.B., Judge T.A., Turka L.A., Wilson J.M., Chen Y. Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer. J. Clin. Invest. 100:1997;1951-1957.
22. Su X., Hu Q., Kristan J.M., Costa C., Shen Y., Gero D., Matis L.A., Wang Y. Significant role for Fas in the pathogenesis of autoimmune diabetes. J. Immunol. 164:2000;2523-2532.
23. Wahlsten J.L., Gitchell H.L., Chan C.C., Wiggert B., Caspi R.R. Fas and Fas ligand expressed on cells of the immune system, not on the target tissue, control induction of experimental autoimmune uveitis. J. Immunol. 165:2000;5480-5486.
24. Sabelko-Downes K.A., Cross A.H., Russell J.H. Dual role for Fas ligand in the initiation of and recovery from experimental allergic encephalomyelitis. J. Exp. Med. 189:1999;1195-1205.
25. Suvannavejh G.C., Dal Canto M.C., Matis L.A., Miller S.D. Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis. J. Clin. Invest. 105:2000;223-231.
26. Giordano C., Stassi G., De Maria R., Todaro M., Richiusa P., Papoff G., Ruberti G., Bagnasco M., Testi R., Galluzzo A. potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science. 275:1997;960-963.
27. Arscott P.L., Baker J.R. Apoptosis and thyroiditis. Clin. Immunol. Immunopathol. 87:1998;207-217.
28. Stassi G., De Maria R., Trucco G., Rudert W., Testi R., Galluzzo A., Giordano C., Trucco M. Nitric oxide primes pancreatic beta cells for Fas-mediated destruction in insulin-dependent diabetes mellitus. J. Exp. Med. 186:1997;1193-1200.
29. Antonsson B., Montessuit S., Sanchez B., Martinou J.C. Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells. J. Biol. Chem. 276:2001;11615-11623.
30. Perlman H., Pagliari L.J., Georganas C., Mano T., Walsh K., Pope R.M. FLICE-inhibitory protein expression during macrophage differentiation confers resistance to Fas-mediated apoptosis. J. Exp. Med. 190:1999;1679-1688.
31. Wang J., Lobito A.A., Shen F., Hornung F., Winoto A., Lenardo M.J. Inhibition of Fas-mediated apoptosis by the B cell antigen receptor through c-FLIP. Eur. J. Immunol. 30:2000;155-163.
32. Medema J.P., De Jong J., van Hall T., Melief C.J., Offringa R. Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein. J. Exp. Med. 190:1999;1033-1038.
33. Djerbi M., Screpanti V., Catrina A.I., Bogen B., Biberfeld P., Grandien A. The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors. J. Exp. Med. 190:1999;1025-1032.
34. Semra Y.K., Seidi O.A., Sharief M.K. Overexpression of the apoptosis inhibitor FLIP in T cells correlates with disease activity in multiple sclerosis. J. Neuroimmunol. 113:2001;268-274.
35. Perlman H., Pagliari L.J., Liu H., Koch A.E., Haines G.K., Pope R.M. Rheumatoid arthritis synovial macrophages express the Fas-associated death domain-like interleukin-1beta-converting enzyme-inhibitory protein and are refractory to Fas-mediated apoptosis. Arthrit. Rheumat. 44:2001;21-30.
36. Djerbi D., Abdul-Majid K.B., Abedi-Valugerdi M., Olsson T., Harris R.A., Grandien A. Expression of the long form of human FLIP by retroviral gene transfer of hemopoietic stem cells exacerbates experimental autoimmune encephalomyelitis. J. Immunol. 170:2003;2064-2073.
37. Marok R., Winyard P.G., Coumbe A., Kus M.L., Gaffney K., Blades S., Mapp P.I., Morris C.J., Blake D.R., Kaltschmidt C., Baeuerle P.A. Activation of the transcription factor nuclear factor-kappaB in human inflamed synovial tissue. Arthrit. Rheumat. 39:1996;583-591.
38. Handel M.L., McMorrow L.B., Gravallese E.M. Nuclear factor-kappa B in rheumatoid synovium. Localization of p50 and p65. Arthrit. Rheumat. 38:1995;1762-1770.
39. Tomita T., Takeuchi E., Tomita N., Morishita R., Kaneko M., Yamamoto K., Nakase T., Seki H., Kato K., Kaneda Y., Ochi T. Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy. Arthrit. Rheumat. 42:1999;2532-2542.
40. Miagkov A.V., Kovalenko D.V., Brown C.E., Didsbury J.R., Cogswell J.P., Stimpson S.A., Baldwin A.S., Makarov S.S. NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc. Natl. Acad. Sci. USA. 95:1998;13859-13864.
41. Refaeli Y., Van Parijs L., London C.A., Tschopp J., Abbas A.K. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity. 8:1998;615-623.
42. Algeciras-Schimnich A., Griffith T.S., Lynch D.H., Paya C.V. Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis. J. Immunol. 162:1999;5205-5211.
43. Schlapbach R., Spanaus K.S., Malipiero U., Lens S., Tasinato A., Tschopp J., Fontana A. TGF-beta induces the expression of the FLICE-inhibitory protein and inhibits Fas-mediated apoptosis of microglia. Eur. J. Immunol. 30:2000;3680-3688.
44. Braley-Mullen H., Chen K., Wei Y., Yu S. Role of TGFβ in development of spontaneous autoimmune thyroiditis in NOD.H-2h4 mice. J. Immunol. 167:2001;7111-7118.
45. Batteux F., Lores P., Bucchini D., Chiocchia G. Transgenic expression of Fas ligand on thyroid follicular cells prevents autoimmune thyroiditis. J. Immunol. 164:2000;1681-1688.
46. Bonfoco E., Stuart P.M., Brunner T., Lin T., Griffith T.S., Gao Y., Nakajima H., Henkart P.A., Ferguson T.A., Green D.R. Inducible nonlymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells. Immunity. 9:1998;711-720.
47. Pinkoski M.J., Droin N.M., Lin T., Genestier L., Ferguson T.A., Green D.R. Nonlymphoid Fas ligand in peptide-induced peripheral lymphocyte deletion. Proc. Natl. Acad. Sci. USA. 99:2002;16174-16179.
48. Griffith T.S., Yu X., Hemdon J.M., Green D.R., Ferguson T.A. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity. 5:1996;7-16.